Synthesis and anticancer activity of novel quinoline-docetaxel analogues was written by Chen, Ming;Chen, Hui;Ma, Jiangwei;Liu, Xueying;Zhang, Shengyong. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2014.Application of 486-73-7 This article mentions the following:
A series of novel quinoline-docetaxel analogs I (R = 2-quinolinylcarbonyl, 3-quinolinylcarbonyl, 1-isoquinolinylcarbonyl, 6-quinolinylcarbonyl, etc., R1 = H, COMe) were designed and synthesized by introducing bioactive quinoline scaffold to C2′-OH of docetaxel. The anticancer activities of these novel analogs were investigated against different human cancer cell lines including Hela, A549, A2780, MCF-7 and two resistant strains A2780-MDR and MCF-7-MDR. The data showed these analogs possessed similar to better cytotoxicity than docetaxel. Compound I (R = 6-quinolinyl, R1 = H) was found to be the most potent one, and its IC50 value against MCF-7-MDR was 8.8 nM (IC50 of docetaxel was 180 nM). This work indicated that the introduction of quinolyl group in docetaxel could enhance cytotoxicity and reduce drug-resistance. In the experiment, the researchers used many compounds, for example, Isoquinoline-1-carboxylic acid (cas: 486-73-7Application of 486-73-7).
Isoquinoline-1-carboxylic acid (cas: 486-73-7) belongs to isoquinoline derivatives. The isoquinoline structure occurs in a considerable number of alkaloids in widely separated plant families. The discovery of chloroquine, the most well-known drug containing this stent, has helped bring about decades of malaria control and treatment.Application of 486-73-7
Referemce:
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem